Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer: What Remains?

J Clin Oncol. 2019 Nov 1;37(31):2807-2814. doi: 10.1200/JCO.19.01981. Epub 2019 Sep 4.
No abstract available

MeSH terms

  • Antineoplastic Agents, Immunological / adverse effects
  • Antineoplastic Agents, Immunological / therapeutic use*
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / metabolism
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / enzymology
  • Head and Neck Neoplasms / pathology
  • Humans
  • Molecular Targeted Therapy
  • Protein Kinase Inhibitors / adverse effects
  • Protein Kinase Inhibitors / therapeutic use*
  • Signal Transduction
  • Squamous Cell Carcinoma of Head and Neck / drug therapy*
  • Squamous Cell Carcinoma of Head and Neck / enzymology
  • Squamous Cell Carcinoma of Head and Neck / pathology
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Immunological
  • Protein Kinase Inhibitors
  • EGFR protein, human
  • ErbB Receptors